Professor, Faculty of medicine, Laval University
Director, Canadian Research Chair in Valvular Heart Disease
Pulmonary Hypertension Research Group
Centre de recherche de lâ€™Institut universitaire de cardiologie et pneumologie de QuĂ©bec (CRIUCPQ)
2725, chemin Sainte-Foy, QuĂ©bec (QuĂ©bec), Canada, G1V 4G5
Philippe Pibarot was born in Toulon, France in 1964. He obtained a doctorate in veterinary medicine (DVM) in 1987 at the University Claude Bernard in Lyon, France. He obtained his PhD degree in biomedical sciences from the University of Montreal in April 1995.
He is currently full professor at the Department of Medicine of Laval University, and director of the Research Group in Valvular Heart Diseases at the QuĂ©bec Heart & Lung Institute. He holds the Canada Research Chair in Valvular Heart Disease. The objective of his research program is to develop and validate novel approaches to improve the diagnosis, prevention, and treatment of valvular heart diseases. He is currently the principal investigator of 3 multicenter studies (TOPAS, PROGRESSA, PROGRAM) funded by Canadian Institutes of Health Research and the Heart and Stroke Foundation of QuĂ©bec. He has published more than 200 articles and presented 190 invited conferences in the course of his career. He received the James Hogg Award from the Institute of Circulatory and Respiratory Health (2006), the AndrĂ© Dupont Award from the Club de Recherches Cliniques du QuĂ©bec (2006), the Preventive Cardiology Award of Excellence from the Heart and Stroke Foundation of QuĂ©bec and 4th International Conference on Preventive Cardiology (2007), the Annual Achievement Award of the Canadian Society of Echocardiography (2010), and the Research Achievement Award, Canadian Cardiovascular Society (2010). He was the chair of the Scientific Program Committee of the Canadian Cardiovascular Congress (2010-2011) and he has been elected as member of the nucleus of the Working Group in Valvular heart Diseases of the European Society of Cardiology.